Drooid Logo
Back to story perspectives

Full Breakdown

U.S. HIV/AIDS Funding Cuts Spark Nationwide and Global Activist Outcry

6/22/2026, 10:20:16 PM

Historical Context of U.S. HIV/AIDS Funding

Since the first AIDS cases were reported in 1981, the United States has financed treatment, prevention and research through Medicaid, the Ryan White program, CDC initiatives and the President’s Emergency Plan for AIDS Relief (PEPFAR). Activist coalitions such as ACT UP and Health Gap helped launch PEPFAR in 2003, a program credited with averting millions of deaths worldwide.

Key Stakeholders and Their Roles

  • Activists and clinicians: Oni Blackstock (HIV physician), Virginia Shubert (Housing Works), Ivy Kwan Arce (ACT UP), Lana Leonard (ACT UP), Mark Harrington (Treatment Action Group), Vincent Wong (former USAID/WHO official).
  • Advocacy groups: Housing Works, ACT UP, Treatment Action Group, Health Gap.
  • U.S. government actors: President Donald Trump, the State Department, Congress, the Department of Health and Human Services (Medicaid rules), the National Institutes of Health (NIH).
  • South African officials: President Cyril Ramaphosa, the South African Health Ministry, spokesperson Foster Mohale.

Recent Policy Changes and Funding Reductions

In June 2026 the Trump administration issued the “One Big, Beautiful Bill Act” Medicaid work-requirement rule, demanding 80 hours of activity per month to retain coverage. Simultaneously, the House proposed a $225 million cut to the Ryan White program, a complete elimination of CDC’s HIV-prevention budget for 2027, and a freeze of NIH HIV research funding. Internationally, the State Department announced a phased drawdown of PEPFAR support for South Africa, reducing the program from $456 million in 2024 to $25 million in 2026.

Quantitative Impact

  • Over 700,000 Americans have died from AIDS; an estimated 40 million worldwide.
  • Roughly 40 % of U.S. people living with HIV rely on Medicaid at any time; 55,000 New Yorkers (? 50 % of the state’s HIV population) depend on Medicaid.
  • The Urban Institute projects 5–10 million Americans could lose Medicaid by 2028 under the new rule.
  • South Africa, with the world’s largest HIV burden (? 7.8 million to > 8 million), received about 18 % of its HIV budget from U.S. aid in 2024.

Official Government Positions

The State Department stated that repeated communications warned South Africa that PEPFAR funding would end unless “policy requests” were met, and emphasized that South Africa “is a middle-income country and is more than capable of supporting its own health programs.” President Trump has framed the drawdown as a response to alleged discrimination against the country’s white Afrikaner minority. South African health officials say they have not received formal notification and are implementing a self-reliance plan.

Activist Criticism and Legal Challenges

Activists argue the Medicaid rule threatens viral-load suppression, calling it “cruel” and “a matter of life or death.” Housing Works and allied groups have flooded the federal comment period and filed lawsuits. ACT UP is pushing a New York single-payer health bill to bypass eligibility paperwork, while Treatment Action Group warns that NIH cuts disproportionately affect research on racial, transgender and immigrant health. Legal challenges to the foreign-aid freeze have reached the Supreme Court.

Conflicting Data and Gaps

Funding figures for PEPFAR vary: some sources list $456 million for 2024, $213 million for 2025, and $25 million for 2026, while others cite “partial” data. South African officials claim no formal notice of the drawdown, whereas U.S. officials assert multiple warnings were issued. Estimates of South Africa’s HIV prevalence differ between 7.8 million and “more than eight million.”

Verbatim Quotes

  • “The HIV community has always been the one to push the scientific community and the government to do the right thing,” — Oni Blackstock, HIV physician
  • “For people with HIV, that’s a matter of life or death, because if your treatment is interrupted, even for a short time, you can lose viral load suppression,” — Virginia Shubert, senior policy adviser, Housing Works
  • “You’ve eliminated an agency that played a major role in ensuring technical excellence, and the state department had not traditionally played that role,” — Vincent Wong, former USAID/WHO official
  • “If the FDA wouldn’t meet with us, we would go do a demonstration, and then they would suddenly want to talk.” — Mark Harrington, co-founder, Treatment Action Group
  • “The United States communicated to the South African government multiple times at many levels that PEPFAR funding would be terminated if they failed to address President Trump’s concerns,” — State Department official
  • “These articles over the last few days, death of people, death, death, horrible death,” — President Donald Trump

Outlook and Pending Developments

A Supreme Court case challenging the PEPFAR freeze is pending, while Congress debates the Medicaid work-requirement and Ryan White cuts. Activists plan further demonstrations and legal actions, and the New York Health Act remains a focal point for state-level reform. The trajectory of U.S. HIV/AIDS funding—both domestic and abroad—will hinge on forthcoming legislative votes and judicial rulings.